Consistent with this, JZL184-mediated dose-dependent tumor regression in A549 xenograft athymic nude mice was associated with decreased numbers of CD31-positive cells and upregulation of TIMP-1-positive cells in xenograft tissue. Here, TIMP1 is linked to neoplasm.